President Donald Trump’s recent executive order on drug prices threatens Roche’s ability to fund the tens of billions of U.S. investment projects the company has planned for the next five years, the company said in a statement. More: Roche to
read moreA new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and more on those who work around the clock to take care of them. More: Genentech pays tribute to moms of
read moreWorkers at an AbbVie manufacturing facility in Carrigtwohill, Ireland, are prepared to begin “industrial action” next week, which could eventually lead to a strike, according to several Irish news outlets. More: AbbVie plant workers in Ireland threaten to strike over
read morePerhaps no literary genre has made quite as big of a splash in recent years as the fantasy-romance segment, colloquially known as “romantasy”—a phenomenon that Organon is capitalizing on in its newest ad campaign. More: Organon taps into 'romantasy' craze
read more
Screening begins for study evaluating LTI-03 in idiopathic pulmonary fibrosi More: Rein Therapeutics initiates renew phase 2 trial for IPF treatment Source: News
read moreThanks to hefty sales increases from kidney disease drug Kerendia and prostate cancer treatment Nubeqa, Bayer’s pharma division weathered the storm from the loss of exclusivity in the U.S. of blockbuster Xarelto in the first quarter. More: As Bayer's restructuring
read more© 1994 - 2026 B.M. Pharmaceuticals